Patent · US Active

Natural compounds and fibrosis

US11185539B2 · kind B2 · utility

0Cited by

1References

6Claims

0Family size

Assignee

MEDIZINISCHE HOCHSCHULE HANNOVER · DE

Inventors

Thomas Thum · Hannover, DE
Katharina Schimmel · Hannover, DE
Quoc-Tuan Do · Orléans, FR
Philippe Bernard · Paris, FR

Key dates

Filing date	Jan 29, 2018
Grant date	Nov 30, 2021
Priority date	—
Expiry date	Jan 29, 2038

Classification

Technology area (CPC G)Physics
CPC primaryG01N33/5061
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to an inhibitor of miR-671-5p for use in a method of preventing or treating fibrosis. Further, the present invention encompasses a kit comprising said inhibitor of miR-671-5p. The present invention also relates to an in vitro method for identifying a compound for preventing or treating fibrosis.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.